{'fraction_non_alphanumeric': 0.03406498055725166, 'fraction_numerical': 0.015907703184754315, 'mean_word_length': 5.519589356798659, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cell-Based Transplantation versus Cell Homing Approaches for Pulp-Dentin Complex Regeneration

Regenerative dentistry has paved the way for a new era for the replacement of damaged dental tissues. Whether the causative factor is dental caries, trauma, or chemical insult, the loss of the pulp vitality constitutes one of the major health problems worldwide. Two regenerative therapies were introduced for a fully functional pulp-dentin complex regeneration, namely, cell-based (cell transplantation) and cell homing (through revascularization or homing by injection of stem cells in situ or intravenously) therapies, with each demonstrating advantages as well as drawbacks, especially in clinical application. The present review is aimed at elaborating on these two techniques in the treatment of irreversibly inflamed or necrotic pulp, which is aimed at regenerating a fully functional pulp-dentin complex.


Introduction
Dental tissue regeneration requires the presence of specialized cells capable of the production of a tissue-specific extracellular matrix (ECM) [1,2]. Stem/progenitor cells used in regenerative medicine are nonspecialized cells, demonstrating the ability of self-renewal and multilineage differentiation [3]. The potential of stem/progenitor cells, whether endogenous or exogenous, to adapt to various environmental niche could be exploited in regenerative endodontics and pulp-dentin tissue regeneration [4][5][6]. Therapeutic application of stem/progenitor cells is mainly dependent on the utilization of the transplanted cells, on suitable scaffolds and in combination with various growth factors to generate fully functional biological tissues [7]. Recently, the success demonstrated in animal models to repair/regenerate dental structures has paved the way for pulp-dentin organ regeneration approaches [8]. (Table 1 and Figure 1). A suggested approach to address problems related to pulp-dentin tissue regeneration relied principally on the use of various sources of stem/progenitor cells, combined with multiple scaffold systems and growth factors [9]. Human mesenchymal stem/progenitor cells (MSCs) have been extracted from many areas of the human body, including the bone marrow, the skin as well as the perivascular, the adipose, and the dental tissues [10][11][12]. Early trials and continuous animal studies were directed to investigate the effectiveness of cell-based transplantation on pulp healing and dentin regeneration [7,13,14]. Autologous transplanted constructs of dental pulp stem/progenitor cells (DPSCs) in combination with platelet-rich fibrin (PRF) proved to promote the regeneration of pulp-dentin-like tissue inside dogs' root canals [15]. A further animal study employing human DPSCs and platelet-derived growth factor

Stem Cells International
(PDGF) constructs transplanted into the emptied root canals of rats induced the creation of globular dentin-like structure with odontoblastic cells and pulp-like tissues [16]. A trial to treat deliberately perforated pulp space of premolars of dogs using autogenous DPSCs, embedded in tricalcium phosphate (TCP) or treated dentin matrix (TDM) scaffolds, showed no dentin formation in all groups while cementum and vascular connective tissues were evident in all specimens [17]. A further study examined microvascular endothelial cells (ECs) coimplanted with rat bone marrow MSCs in pulpotomized rat models. Interestingly, after 14 days, immunohistochemical examination demonstrated healing of the pulp with complete dentin bridge formation in teeth implanted with MSCs and ECs, while those implanted with MSCs lacked the completion of the formed dentin bridge [18]. A further noninvasive regenerative pulpal approach was tested, using mobilized DPSCs freshly extracted from upper canine teeth of dogs, followed by autologous DPSCs transplantation in pulpectomized permanent teeth with apical closure. The study revealed that pulp tissue was completely regenerated 90 days following cell transplantation [19]. A novel trial on a rat model for dental pulp regeneration employed pulpotomized rat teeth, which were treated using buildups of rat bone marrow mesenchymal stem cells (BMMSCs). The tested buildups were implanted into the pulpotomized pulp chambers for 3, 7, or 14 days and then examined immunohistochemically. At 7 days, the pulp tissue was regenerated in almost the whole implantation area and regeneration continued to progress for 14 days with differentiation of odontoblast-like cells beneath the dentin at the margin of the implanted area evidenced by a detected nestin expression. Also, quantitative gene expression analysis disclosed the expression of sialophosphoprotein mRNA in the implanted area, suggesting the abundance of odontoblasts [20]. Chitosan hydrogel scaffold containing autologous DPSCs was further transplanted in the necrotic immature permanent teeth of dogs, regenerating pulp-and dentin-like tissues with complete root maturation radiographically and histologically [21]. However, not all the reported studies were successful. Implanting DPCs in TCP and TDM scaffolds, combined with transforming growth factor β, ascorbic acid 2-phosphate, and ascorbic acid 3-phosphate, did not promote the formation of a dentin bridge [17]. Also, porcine

Stem Cells International
DPCs failed to heal or regenerate partial pulpotomy defects of minipigs. Moreover, hyperemia in the residual pulp and external root resorptions were evident in the radicular area of all the treated teeth [22]. On the contrary, another investigation demonstrates that when combining collagen scaffold with granulocyte colony-stimulating factor (G-CSF), a total recovery of the pulp tissue was achievable in the pulpectomized teeth [19].
It was appealing to seek more uncommon supplementary derivatives to enhance stem/progenitor cells' activation and differentiation, dragging attention towards nondental medications. An animal study reported that a common drug used to treat hyperlipidemia, Simvastatin (SIM), succeeded in stimulating canine DPSCs, promoting pulp and dentin regeneration following pulpotomy [23]. Further animal studies suggested using glycogen synthase kinase (GSK-3) antagonists, a drug usually applied for the treatment of neurological disorders, which proved successful as a capping material of the pulpal exposure site, promoting dentin formation [24,25]. Another animal study proved that pulp regeneration was enhanced in aged dogs' teeth by trypsin pretreatment of allogenically transplanted mobilized DPSCs [26].
A case report treating accidental root perforation of a mature permanent tooth, utilizing allogenic umbilical cord mesenchymal stem cells (UCMSCs) encapsulated in a plateletpoor plasma-(PPP-) based bio scaffold, demonstrated a clinically normal pulpal tissue in terms of vitality testing, palpation, and percussion testing at six-month and one-year follow-ups [27]. Moreover, two case reports showed a successful management of periapical lesions in permanent teeth treated with stem/progenitor cells from human exfoliated deciduous teeth (SHED), with the treated teeth responding normally to electric pulp testing and periapical tissue healing observed and maintained up to one year [28].
Collectively, cell-based therapeutic applications in the dental field and specifically dentin-pulp tissue regeneration still face a number of challenges. Future strategies should be directed towards overcoming these challenges and obstacles using an ideal combination of growth factors with properly matching scaffolds [17,22]. Secure and controllable practice must be strictly followed to translate stem/progenitor cell research into human models, starting from protocols of stem/progenitor cells' tissue harvesting, the biocompatibility of the used scaffolds and biomaterials involved, and the safety of the technique itself and the predicted outcome [29,30]. Finally, the endless mix and match trials between scaffolds of different origins, as well as electing the suitable growth factor/biological mediator, could govern the success or failure of regenerating a specialized tissue when employing the stem cell-based therapy [31].
1.2. Stem/Progenitor Cell Homing. As mentioned above for pulp-dentin complex regeneration, two strategies could be applied, namely, the cell-based transplantation therapy or the cell homing. In the latter, the regeneration is accomplished via chemotaxis of host endogenous cells to the injured tissue via biological signaling molecules. Stem/progenitor cell homing can be defined as the potential of stem/progenitor cells, whether endogenous or exogenous, to migrate into an environmental niche. MSCs can be delivered in situ or intrave-nously, or they can be recruited to sites of injury, through migration and homing [32]. Clinically, cell homing for pulpdentin complex regeneration might be simpler and more economical to perform compared to the cell-based therapy and readily performed by clinicians without special training. (Figure 2). Homing approaches can be either systemic or nonsystemic. In nonsystemic homing, MSCs are locally transplanted at the selected tissue and are then directed to the region of injury through a chemokine gradient. Oppositely, in systemic homing, MSCs are delivered or recruited endogenously into the circulation and then undergo a series of processes, leaving the bloodstream and moving towards the site of injury. These complex processes involve tethering and rolling, activation, arrest, transmigration or diapedesis, and migration [33,34]. Tethering is mediated by selectins on endothelial cells. MSCs exhibit CD44, which binds to the selectins and starts rolling along blood vessels [35]. This is followed by chemokinemediated activation [36]. MSCs express the chemokine receptors CXCR4 [37] and CXCR7 [38,39]. The stromal cellderived factor (SDF-1) is the ligand to these receptors, where it binds to them to enhance homing to different tissues. Then, comes the process of arrest mediated by integrins, mainly by CD49d (α4β1), which unites with VCAM-1 (CD106) present on endothelial cells [40]. In order to cut across the endothelial basement membrane, a process known as diapedesis or transmigration, MSCs produce matrix metalloproteinases (MMPs) mainly MMP-1, which plays a crucial role in tissue infiltration by MSCs [41]. Finally, MSCs migrate to injury sites. This step is regulated by chemotactic signals, produced as a reaction to tissue impairment. Numerous growth factors, such as insulinlike growth factor IGF-1 and platelet-derived growth factor (PDGF), can act as chemokines for MSCs [42]. Moreover, tumor necrosis factor (TNF-α) increases MSCs movement towards chemokines by increasing their expression of CCR3, CCR4, and CCR2 receptors [4,43,44]. In addition, the inflammatory cytokine interleukin-(IL-) 8 was proved to enhance migration of MSCs towards regions of injury [45,46] and further promotes them to produce regenerative growth factors, such as vascular endothelial growth factor (VEGF) [47].

Routes of Administration and Delivery Methods.
One important point in MSCs transplantation and their consequent therapeutic efficiency is the route of administration to provide the ultimate regenerative benefits with the least adverse effects. The most common delivery methods for MSCs are either by intravenous (IV) or intra-arterial infusion (IA) or by direct intratissue injection [48]. Several experimental studies proved the superiority of IA and IV delivery modes over other delivery routes [49,50]. The IV route was proved to be the most convenient route for MSCs transplantation. It is less traumatic and reproducible and enhances widespread distribution in the affected regions, enhancing various biological effects [51]. However, this delivery method in nearly all cases causes entrapment of MSCs in the lungs, causing undesirable adverse effects, including embolisms. The reason for this lung entrapment relies probably on the amalgamation of physiological and mechanical factors, such as 6 Stem Cells International the small size of blood capillaries, the vast network of capillaries, and the great adhesive characteristics of MSCs. It was also demonstrated that some cells could produce calcium deposits within the capillaries [52]. On the contrary, the IA route can be more efficient, as it provides a straightforward route to the injury site with an increased degree of cellular endurance and engraftment [53,54]. Several studies proved the superiority of IA delivery route over the IV one. They demonstrated enhanced functional and histological results in IA delivery compared with IV injection of MSCs [49,55]. IA transplantation of MSCs increases cellular migration, cellular density, and the number of homing MSCs to the target tissue, when compared to IV injection [56,57]. Du et al. in a comparative study demonstrated greater angiogenesis and increased functional recovery with IA transplantation compared to IV injection utilizing human BM-MSCs in a rat model of ischemia [58]. Lundberg et al. confirmed these findings in a model of traumatic brain injury [59]. The main reason for the superiority of IA transport over IV mode is that the IA approach can bypass the pulmonary circulation and filtering organs, such as liver and spleen [60], thereby avoiding MSCs entrapment in lungs and liver [54], with a significant rise in number of cells with a more consistent cellular dissemination in target tissues [61,62]. This will eventually lead to increased cell homing and improved therapeutic outcomes [58].
However, a probable limitation for the IA route is the possibility of vascular blockage in small arterioles and capillaries resulting in strokes. This may be attributed to the existence of large MSCs in the 20-50 μ size range [63,64]. Several attempts have been performed to enhance the safety of IA transplantation via regulating infusion velocity and cell dosage [63,65]. Moreover, real-time MRI could provide a useful tool in making the procedure more accurate and predictable, which is of ultimate importance for translation to clinical practice [66].
Direct injection delivery mode has the advantage of accurate localization of cells, despite being invasive. However, it has been proved that aside from the delivery route, only 1∼5% of delivered cells disseminate within the target region for regeneration. The count of cells in the target region may thus be enhanced by maximizing the injection volume or enriching the cell concentration in the injectable volume [67][68][69]. In addition, the expression of adhesion molecules can promote homing of delivered MSCs [70,71]. In this context, several approaches have been made to enhance MSC homing efficacy. Homing (Figure 2). Cellular homing relies principally on specialized molecular interactions, not just passive diffusion. One of the main challenges facing MSCs therapeutic applications is enhancing their homing abilities [72].

Stem Cells International
Among the challenges is the fact that the expression of homing molecules, as CXCR4, is relatively low on MSCs [37,73], and the in vitro expansion of MSCs further decreases the expression of their homing molecules [74,75]. Thus, numerous approaches have been suggested to enhance MSC homing. Among these is targeted delivery, which relies on direct delivery of MSCs into the target region, employing nonsystemic rather than systemic homing [76]. In addition, magnetic guidance of MSCs to target tissues proved greater homing efficiency [77]. Furthermore, genetic modifications of MSCs via overexpression of homing factors such as VLA-4 and CXCR4 through viral transduction proved increased efficiency [78,79]. Cell surface engineering approaches were suggested to modify the selectin ligand CD44, via transforming it into HCELL (the ligand for E-and L-selectin that MSCs utilize for homing), as MSCs normally express CD44, but not HCELL [80]. It was further demonstrated that coating MSCs with hyaluronic acid could upregulate CD44 expression [81]. Moreover, hypoxic conditions enhance hypoxia-inducible factor-(HIF-) 1a, which upregulates the expression of CXCR4 [82], CX3CR1 [83], and CXCR7 [84,85].
A further strategy addressed modifying the target tissues, via overexpression of chemokines or via implantation of chemokine-coated scaffolds [86]. This allows tissues to be a more appealing target for homing MSCs. Moreover, irradiation of target tissues increases the expression of SDF-1, upregulating in MSC engraftment [87,88] and homing [89]. Pulsed ultrasound applied to the target tissue may also enhance MSC homing [90], via altering gene expression of cytokines as bone morphogenic protein-2 (BMP-2), interleukins (IL-1α, IL-6, and IL-10), TNF-α, and growth factors such as epidermal growth factor (EGF), fibroblast growth factor (FGF), VEGF, and PDGF [91], causing disorganization of endothelial linings, enhancing vascular permeability, increasing secretion of SDF-1 on the tissue of interest, and upregulating CXCR4 expression [92].
1.6. Cell Homing for Pulp-Dentin Complex Regeneration (Revascularization) (Table 2 and Figure 3). Regenerative endodontics represents an alternative to root canal treatment, which is aimed at replacing the inflamed and necrotic pulp tissue with regenerated pulp-like tissue [93]. In this context, revascularization approaches of affected dental pulp were suggested as an innovative strategy to overcome the drawbacks associated with classical root canal treatment methods (e.g., fracture of the teeth and loss of vitality) [94]. A human study on mature necrotic teeth with large radiolucency concluded that the regenerative endodontic approaches have a success rate similar to nonsurgical endodontic treatment as a therapeutic alternative for mature necrotic teeth with radiolucency [95]. It could maintain the pulp vitality, leading to a reduction of apical periodontitis and enhance the periapical healing mechanism [96]. Basically, pulp revascularization is the reestablishment of angiogenesis inside the root canal but without the repopulation of odontoblasts, while the pulp regeneration means angiogenesis with presence of odontoblastic layer lining the dentinal surface, nociceptive as well as parasympathetic and sympathetic nerve fibers, interstitial fibroblasts, and stem/progenitor cells, which replenish the pulp cells in the newly regenerated pulp tissue [97]. According to American Association of Endodontists' (AAE) Clinical Considerations for a Regenerative Procedure, the primary goal should be the resolution of clinical symptoms/signs and elimination of apical periodontitis. The secondary goal should address the canal wall thickening and/or continued root maturation [98].
Pulp revascularization could be considered a type of cell homing strategy for pulp-dentin complex regeneration. This clinical procedure depends on the delivery of a blood clot (scaffold) inside the root canal, growth factors (mainly from platelets and dentin), and stem/progenitor cells. The stem/progenitor cells of interest in revascularization are SCAP (stem cells of apical papilla) because of their anatomical positioning immediately adjacent to the termination of the root canal system, permitting easy cell delivery to the root canal [99,100] and the greater superiority for dentin-like tissue formation [101,102]. The root canal system is first disinfected with a combination of antibiotics or calcium hydroxide. In the second visit, the irrigation protocol during this clinical procedure is very critical as for the regeneration procedure to be successful; the irrigants should have bactericidal/bacteriostatic properties as well as an ability to promote survival and proliferative capacity of the patient's stem/progenitor cells. The irrigation protocols that include 17% EDTA promoted SCAP survival and attachment to the root canal dentinal wall [103].
Animal studies were performed to examine the tissues formed after revascularization, demonstrating ingrowth of cellular cementum-like tissues, formation of pulp-like tissue, thickening of the canal walls, closure of the root apex, and disappearance of periapical radiolucency [104,105]. Histological sections were also performed in humans after fracture of a revascularized immature tooth (3.5 weeks after revascularization), showing that the canal was filled with loose connective tissue and a layer of flattened odontoblast-like cells lined along the predentin. Layers of epithelial-like cells, similar to the Hertwig's epithelial root sheath, further surrounded the root apex [106]. Alternative endodontic therapy is now possible, using the patient's own blood samples, where PRF and PRP are introduced inside the root canal. Easier and successful efforts for pulp revascularization and pulp tissue regeneration were reported by using evoked bleeding (EB), where the blood clot acts as a protein scaffold and interacts with endogenous stem cells and growth factors already abundant in the adjacent bone marrow tissues [107]. The highest reported cytokines and growth factors found in PRF are IL-1β, IL-6, IL-4, TNF-α, PDGF, VEGF, IGF-1, EGF, and transforming growth factor β1 (TGFβ1) [108], while PRP contains FGF, PDGF, VEGF, IGF-1, EGF, and TGFβ1 [109]. The superiority of PRP came from releasing an elevated number of proteins at early time intervals whereas PRF showed a sustained production of bioactive molecules throughout a duration of 10 days [110]. In the blood clot technique, the growth factors are released from the dentin matrix after conditioning of the dentin using EDTA (ethylene diamine tetra acetic acid) 17%-pH 7.2 during the revascularization technique. Thus, the dentin matrix acts as a reservoir of bioactive molecules, which provides a vital source of cell signaling molecules for initiating repair, including TGFβ1, bone 8 Stem Cells International      14 Stem Cells International morphogenetic proteins (BMPs), and VEGF [111]. PRF has proved to be an appropriate substitute to the blood clot technique, especially in cases where bleeding was very difficult to be obtained [107]. PRP and blood clotting technique used as scaffolds in immature traumatized permanent teeth with necrotic pulps also gave very good results [112]. In a clinical study on 30 patients with maxillary necrotic permanent immature central incisors, treating one group with PRP and the other with PRF scaffolds, teeth survived during the 12-month follow-up period. The teeth revealed marginal increase in radiographic root width and length, an increased periapical bone density, and a narrowing in apical diameter [113]. Other studies compared the effect of PRF, PRP, and the blood clot technique in the revascularization of necrotic teeth with open apex, demonstrating continued root development and maintenance of functionality, following different follow-up periods, yet with some teeth not responding to vital testing [2,5,6,[114][115][116][117][118][119][120][121][122]. A further investigation induced bleeding in root canals and used PRF in mature necrotic teeth, showing a regain in pulp sensibility [123].
In a further study, Kim et al. were able to regenerate toothlike structure using cell homing approach [124].

Pixagon Art
BMMSCs are able to differentiate towards connective tissue, bone, adipose, muscle tissues, cartilage and endothelium and also towards other lineages such as renal, lung, hepatic and neural cells.

Stem Cells International
Still, one of the drawbacks of the revascularization found among cases treated with this approach is the occasional intracanal calcification, which in some cases may progress to complete obliteration of root canals, affecting the normal function of the dental pulp tissues. This drawback could be attributed to multiple contributing factors such as the type of medicaments and the induction of intracanal bleeding [125,126]. A recent review article evaluated the long-term outcomes of the apexification and the regenerative techniques in treating traumatized immature teeth with pulp necrosis and apical periodontitis, showing that the endodontic regenerative techniques appeared superior to apexification techniques in terms of root lengthening and root wall thickening [127].

Cell-Free Approach for Pulp-Dentin Complex Regeneration.
Relying on "cell homing" concept, the cell-free approach is aimed at regeneration by enhancing proliferation, migration, and differentiation of intuitive stem/progenitor cells present near the root apex [128]. It was proposed that stem/progenitor cells' niches could initiate an appropriate microenvironment by releasing immunoregulatory molecules and enhancing paracrine effects to promote the differentiation of endogenous stem cells [129,130]. Additionally, natural molecules and bioactive compounds have been proved to promote dentinogenesis [131,132].
Conditioned medium (CM) can be described as the molecules released from living cells into the surrounding extracellular environment [133]. CM was found to stimulate cellular immunomodulation, proliferation, migration, and tissue regeneration [133][134][135] as it contains abundant amounts of proteins, lipids, nucleic acid, growth factors, cytokines, chemokines, and extracellular vesicles [136]. A recent study combined hDPSC conditioned medium with MTA for direct vital pulp therapy. It was assumed that the abundance of angiogenic growth factors such as PDGF, FGF, and VEGF [137] and immunomodulatory cytokines such as IL-6 and IL-8 [138] secreted by DPSCs and collected in hDPSCs' conditioned medium could modulate the inflammatory and regenerative processes in the dental pulp tissue, improve the orientation of the newly formed hard tissue, and enhance formation of dentin bridges [139].
Extracellular vesicles (EVs) derived from MSCs function as paracrine mediators in tissue regeneration and repair and resemble to a great extent the therapeutic efficacy of parental MSCs [140]. Extracellular vesicles (EVs) are defined by the MISEV2014 and the updated MISEV2018 as "particles naturally released from the cell that are delimited by a lipid bilayer membrane and are incapable of self-replication, i.e., do not contain a functional nucleus." EVs are a collective name including many subtypes of cell-released, membranous particles, known as microvesicles, microparticles, exosomes, oncosomes, ectosomes, and apoptotic bodies. EVs are characterized by the presence of luminal and transmembrane proteins and attenuation of extracellular or cellular non-EV proteins [141,142]. The term "exosomes" usually refers to EVs that are formed by the endosomal system, opposite to ectosomes (microparticles and microvesicles) that bud from the plasma membrane. Particularly, intraluminal vesicles are unleashed into the extracellular environ-ment as exosomes when the multivesicular body coalesces with the plasma membrane [143]. Exosomes are identified by their small diameter (40-100 nm) [144]. Moreover, they possess large amounts of tetraspanins (CD81, CD9, and CD63) and annexins, which are commonly used for their characterization [145].
Additionally, exosome vesicles were claimed to possess the ability to induce odontogenesis and augment dental pulp regeneration [146]. Accordingly, a study based on extracted exosome-like vesicles from rat Hertwig's epithelial root sheath (HERS) was tested. Dental pulp cells (DPCs) were united with HERS cell-derived exosome-like vesicles in an in vivo tooth root slice model, triggering the regeneration of hard reparative dentin-like tissue and soft tissue rich in blood vessels and neurons [147]. Moreover, in an interesting study, when SCAPderived exosomes (SCAP-Exo) were put into a root slice containing BMMSCs and transplanted into immunocompromised mice, dentin and dental pulp-like tissues were formed in the root canal. Besides, when SCAP-Exo were evaluated in vitro, it was reported that dentin sialophosphoprotein expression and hard tissue deposition in BMMSCs treated with SCAP-Exo were significantly upregulated [148]. In another study, EVs were derived from DPSCs and EVsfibrin gel constructs were manufactured as an in situ delivery system. Afterwards, DPSCs and endothelial cells were cocultured in the constructs. It was reported that EVs-fibrin gels promoted dental pulp regeneration by stimulating collagen deposition and enhancing angiogenesis through upregulating the expression of VEGF [149].
It is further well established that the usage of MSC-derived EVs possesses numerous advantages. First, it overcomes the ethical issues that limit the clinical translation of MSCs. Second, transplanting cells, which might have mutated DNA, can be avoided. Third, the dose of delivered MSCs rapidly declines posttransplant, in contrast to MSC-derived vesicles, which could attain a higher dose. Fourth, EVs are relatively small and can circulate easily, opposite to MSCs, which are too large to circulate smoothly via capillaries. However, the main disadvantage of utilizing MSC-derived vesicles is that they are static and cannot be produced in vivo. Moreover, the efficacy of EVs requires standard parameters to produce EVs of known content, develop storage techniques that preserve vesicle efficacy, and assess their therapeutic potential in well-controlled clinical trials [140].

Conclusion
Regenerative dentistry is no longer a dream, thanks to the current efforts to imply stem/progenitor cell-based techniques to enhance the regeneration of the pulp-dentin complex and to replace conventional endodontic pulp therapy. Yet, such novel therapies dictate careful testing first in vitro and in animal models, prior to human clinical translation [150]. Cell-based therapies still face many challenges, mainly economical and ethical concerns. Thus, efforts started to target cell homing for pulp-dentin complex regeneration as a simpler, safer, and reasonably priced approach compared to the cell-based transplantation therapy. However, the success and safety of MSCs administered via IV or IA routs, as well as directing such cells 16 Stem Cells International towards the injured tissues, are not always guaranteed. Despite the great advancements in pulp-dentin complex regeneration through cell homing in the past years, they require further investigations and development. Cell homing techniques need to be examined in more realistic models, starting with animals then humans. Moreover, clinical trials are crucial to point out possible indications and contraindications. Thus, numerous aspects still need to be resolved to make it applicable and with predictable outcomes in clinical dental practice. The perspective of replacing conventional endodontic therapy, while retaining the tooth vitality in a practical and relatively safe way, provides hope for the clinical dental practice. Finally, any minor step towards the future is counted as an additional profit that must be preciously handled and searched thoroughly to be utilized later in the field of regenerative dentistry.

Data Availability
Data are available on request.

Conflicts of Interest
The authors declare that they have no conflicts of interest. Stem Cells International